Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06055309Phase 1Completed
Phase 1, single-arm trial of cannabis, sponsored by University of Arkansas. Primary endpoints: Vital Signs - Blood Pressure at 5.5 hours, Vital Signs - Respiration at 5.5 hours and 9 more. Started May 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06055309.